Octreotide

In some countries, this medicine may only be approved for veterinary use.

In the US, Octreotide (octreotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly, Carcinoid Tumor, Diabetes - Type 1, Diarrhea, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Small Bowel or Pancreatic Fistula and Vasoactive Intestinal Peptide Tumor.

US matches:

• Octreotide


• Octreotide Kit


• Octreotide injectable


• Octreotide Injection, Intramuscular


• Octreotide Acetate

UK matches:

• Octreotide Mayne
• Octreotide 100microgram / ml solution for injection (SPC)
• Octreotide 200micrograms / ml solution for injection (SPC)
• Octreotide 50 micrograms/1 ml Solution for injection (SPC)
• Octreotide 500 micrograms/1 ml Solution for Injection (SPC)
• Octreotide 500micrograms / ml solution for injection (SPC)
• Octreotide 50micrograms / ml solution for injection (SPC)
• Octreotide Hospira 100 micrograms/1 ml Solution for Injection (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01CB02

CAS registry number (Chemical Abstracts Service)

0083150-76-9

Chemical Formula

C49-H66-N10-O10-S2

Molecular Weight

1019

Therapeutic Categories

Hemostatic agent, gastrointestinal tract

Growth hormone release inhibiting hormone analogue (analogue of somatostatin)

Chemical Name

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamido cyclic (2-7) disulfide

Foreign Names

• Octreotidum (Latin)
• Octreotid (German)
• Octréotide (French)
• Octreotida (Spanish)

Generic Names

• Octreotide (OS: BAN, USAN)
• Octréotide (OS: DCF)
• SMS 201-995 (IS: Sandoz)
• Octreotide Acetate (OS: BANM, JAN, USAN)
• SMS 201-995 ac (IS)

Brand Names

• Acrotid
  Sun Pharma, Peru



• Azestan
  AC Farma, Peru



• Cryostatin
  Cryopharma, Mexico



• Longastatina
  Italfarmaco, Italy



• Nomactril
  Ivax, Mexico



• Octreotida Tosicina
  Support Pharma, Spain



• Octreotide Mayne
  Hospira Nordic, Denmark



• Octride
  Chalver, Colombia; Sun, Myanmar



• Samilstin
  LPB, Italy



• Sandostatin
  Novartis, Argentina; Novartis, Austria; Novartis, Bosnia & Herzegowina; Novartis, Bulgaria; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Spain; Novartis, Greece; Novartis, Hong Kong; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, India; Novartis, Iceland; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Norway; Novartis, New Zealand; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, Venezuela; Novartis, South Africa; Novartis Pharma, Vietnam; Novartis Pharmaceuticals, Peru



• Sandostatin (veterinary use)
  Novartis Animal Health, United Kingdom



• Sandostatin LAR
  Novartis, Australia; Novartis, Ecuador; Novartis, Indonesia; Novartis, Turkey; Novartis, Taiwan



• Sandostatina
  Novartis, Italy; Novartis, Portugal



• Sandostatine
  Novartis, Tunisia



• Bendatreotid
  Bendalis, Germany



• Longastatina LAR
  Italfarmaco, Italy



• Octreotid Hexal
  Hexal, Germany



• Octreotide Acetate
  APP, United States; Bedford, United States; Hospira, Australia; Sun, United States; Teva USA, United States



• Octreotide Hospira
  Hospira, Netherlands; Hospira, Norway; Hospira, New Zealand; Hospira Nordic, Sweden



• Octréotide Hospira
  Hospira, France



• Octreotide Sandoz
  Sandoz, Netherlands



• Octreotide
  Hospira, Italy



• Sandostatin Euro
  Euro, Netherlands



• Sandostatin
  Novartis, Australia; Novartis, Canada; Novartis, Switzerland; Novartis, China; Novartis, Germany; Novartis, Estonia; Novartis, Finland; Novartis, United Kingdom; Novartis, Georgia; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Ireland; Novartis, Japan; Novartis, Sri Lanka; Novartis, Lithuania; Novartis, Malaysia; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, United States



• Sandostatin LAR
  Novartis, Argentina; Novartis, Austria; Novartis, Brazil; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Spain; Novartis, United Kingdom; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Iceland; Novartis, Italy; Novartis, Japan; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Malta; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, United States; Novartis, Venezuela; Novartis Pharmaceuticals, Peru



• Sandostatina LAR
  Novartis, Bulgaria



• Sandostatine LAR
  Medcor, Netherlands; Novartis, Netherlands



• Sandostatine
  EU-Pharma, Netherlands; Novartis, Belgium; Novartis, France; Novartis, Netherlands

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.